Because platinum forms DNA crosslinks to kill tumor cells, we are currently examining whether genetic polymorphism of FA genes identified as important in determining cancer risk is also associated with individual susceptibility to platinum chemotherapy in lung cancer treatment. The gene discussed is FANCA; the disease is neoplasm.